nivolumab,pembrolizumab
merck,bms
['nivo', 'pembro']
finally back at #asco2022 ! we shared our data on extended interval dosing icis (pembro q6w and nivo q4w). a multicenter effort from 37 european institutions. looking forward to final data 
Medical Doctor - Medical Oncologist @Università Politecnica delle Marche - ESMO Research Fellow @ErasmusMC